SAKAR vs ZOTA: Stock Comparison

Sakar Healthcare Limited vs Zota Health Care LtdUpdated 25 Aug 26, 4:08 PM ISTNSE & company filings

Zota Health Care Ltd is the larger company by market capitalisation. Sakar Healthcare Limited shows a higher ROE, lower leverage and a higher ROCE, while Zota Health Care Ltd shows a lower P/E, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SAKAR leads 8; ZOTA leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SAKARZOTA

Valuation lens

What price are you paying?

Market CapContext only
₹1,973 Cr
₹3,737 Cr
P/E RatioZOTA has the lower reading
56.29x
-35.61x
P/B RatioZOTA has the lower reading
6.26x
5.44x
EPSSAKAR has the higher reading
₹13.68
₹-30.6
Book ValueContext only
₹145.98
₹200
Dividend YieldZOTA has the higher reading
0%
0.09%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ZOTA is the larger company
₹3,737 Cr vs ₹1,973 Cr
P/E Ratio
ZOTA has a lower P/E
-35.61x vs 56.29x
P/B Ratio
ZOTA has a lower P/B
5.44x vs 6.26x
EPS
SAKAR has higher earnings per share
₹13.68 vs ₹-30.6
Dividend Yield
ZOTA has a higher dividend yield
0.09% vs 0%
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 40.1%
EPS Growth (TTM YoY)
SAKAR has faster EPS growth
87.2% vs 0%
Qtr Sales Growth
ZOTA has stronger quarterly sales growth
67.6% vs 41.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSAKARZOTA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricSAKARZOTA
Live Price₹884.85₹1,076.8
Day Change-1.63%-1.62%
Volume77,1751.1 L
52-Week High₹980₹1,740
52-Week Low₹345.5₹1,026.2
Distance from 52W High-9.71%-38.11%

Valuation

MetricSAKARZOTA
Market Cap₹1,973 Cr₹3,737 Cr
P/E Ratio56.29x-35.61x
P/B Ratio6.26x5.44x
EPS₹13.68₹-30.6
Book Value₹145.98₹200
Dividend Yield0%0.09%

Growth

MetricSAKARZOTA
Revenue Growth (TTM YoY)40.1%67.7%
EPS Growth (TTM YoY)87.2%0%
Qtr Sales Growth41.5%67.6%
Qtr Profit Growth91.3%-204%

Profitability & Leverage

MetricSAKARZOTA
ROE9.99%-15%
ROCE12.7%-8.47%
Net Margin12.11%-13.98%
Operating Margin27.4%0.49%
Debt to Equity0.17x0.39x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSAKARZOTA
Promoter Holding52.52% 0.34 pp49.38%
FII Holding12.13% 0.81 pp7.92% 0.29 pp
DII Holding11.37% 0.05 pp6.75% 0.35 pp
Public Holding23.98% 1.11 pp35.96% 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Sakar Healthcare Limited and Zota Health Care Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.